trending Market Intelligence /marketintelligence/en/news-insights/trending/z2-bIA3kKc6B92tdgLMiTg2 content esgSubNav
In This List

Insulet appoints 2 directors

Blog

Gauging Supply Chain Risk In Volatile Times

Blog

Insight Weekly: Banks' efficiency push; vacuuming carbon; Big Pharma diversity goals

Blog

The Future of Risk Management Digitization in Credit Risk Management

Blog

Climate Credit Analytics: Diving into the model


Insulet appoints 2 directors

Insulet Corp. appointed Michael Minogue and James Mullen to its board of directors.

The company also said that Regina Sommer and Joseph Zakrzewski retired from the board.

Minogue is CEO, president and chairman of medical device manufacturer ABIOMED Inc.

Mullen is CEO of pharmaceutical contract development and manufacturing organization Patheon N.V., which is in the process of being acquired by Thermo Fisher Scientific Inc.